StonvexLoading…
StonvexStonvexStonvexCore line items from COCH's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $241.00K | $225.00K | $316.00K | $237.00K |
Operating Income | $-22.27M | $-19.26M | $-18.36M | $-8.71M |
Net Income | $-23.76M | $-20.80M | $-29.92M | $-15.92M |
EPS (Diluted) | $-1.23 | $-1.49 | $-2.54 | $-1.57 |
Total Assets | $8.56M | $11.54M | $8.27M | $2.56M |
Total Liabilities | $20.32M | $30.38M | $10.05M | $38.75M |
Cash & Equivalents | $3.74M | $5.48M | $4.22M | $183.00K |
Free Cash Flow OCF − CapEx | $-18.38M | $-18.93M | $-17.24M | $-9.02M |
Shares Outstanding | 23.26M | 18.79M | 19.55M | 10.12M |